Background
Introduction
to MI remains completely unknown. We compared the age-related difference in cardiac function and pathological changes responsible for the increased susceptibility to myocardial ischemia in intermediate-aged hearts following acute I/R injury. I/R injury typically develops in the rat left anterior descending (LAD) ligation model, representing an opportunity for examining this important issue. The present study was designed to examine the effects of the long-term consumption of ginseng extract on the functional and morphological changes of the myocardium in naturally middle-aged rats. Herein, we investigated 1) differences between young and intermediate-aged rats after RSE treatment for 90 days in the occurrence of infarct size and left ventricular (LV) function following LAD ligation-induced MI and 2) potential mechanisms responsible for the age-related differences observed after ginseng treatment.
Materials and Methods Animals
Male Sprague-Dawley rats were purchased from the Laboratory Animal Services Center, the Chinese University of Hong Kong, Hong Kong. The animals were acclimated for 7 days under a 12-hour light/12-hour dark cycle at room temperature (22°C ± 1°C). A chow diet and water were provided ad libitum. Animal care and treatment procedures were performed in accordance with the Institutional Guidelines and Animal Ordinance (Department of Health, Hong Kong Special Administrative Region) and approved through the Committee on the Use of Human and Animal Subjects in Teaching and Research of the Hong Kong Baptist University.
Materials
The standardized ginseng extract (RSE) was prepared using the dried root of P. ginseng C.A. Meyer through ethanol extraction. The contents of the ginsenosides Rg1, Re, Rb1, Rc, Rb2, Rd, Rk3, (20S)Rg3, (20R)Rg3, Rk1 and Rg5 were 8.08, 7.64, 11.58, 10.35, 6.67, 4.50, 0.06, 0.29, 0.09, 0.08, and 0.10 mg/g, respectively, determined through HPLC analysis. Dorminal (20%; 1 ml contains 200 mg pentobarbital sodium) was purchased from Alfasan, and 2, 3, 5-triphenyltetrazolium chloride (1612634) was obtained from International Laboratory USA (San Bruno, CA, USA). Other materials used in this study are specified in detail in the sections below.
Experiment design
Thirty young rats at the age of 3 months and thirty intermediate-aged rats at the age of 15 months were randomized into six groups, respectively, 10 rats for each group as follows: 1) young vehicle-treatment group with sham operation; 2) young vehicle-treatment group with I/ R; 3) young RSE-treatment group with I/R; 4) intermediate-aged vehicle-treatment group with sham operation; 5) intermediate-aged vehicle-treatment group with I/R; 6) intermediate-aged RSE-treatment group with I/R. The rats are treated either with RSE (dissolved in distilled water at 10mg/ml) at a dosage of 80 mg/kg/day or with vehicle (distilled water at 8ml/kg) through gavage for 90 days as indicated in the group information. On Day 90, the rats underwent sham operation or myocardial I/R (I/R). Of 10 rats in each group, 6 were for ventricular function and infarct size measurement and 4 for western blot analysis and histological assessments. Myocardial I/R was induced through LAD coronary artery ligation. Briefly, under anesthesia with sodium pentobarbital (70 mg/kg body weight) and artificial ventilation (rodent ventilator IITC SAR 830/P), the heart was exposed via left lateral thoracotomy, followed by pericardiectomy. The LAD coronary artery was occluded using a 6-0 silk suture and a small vinyl tube. Ischemia was established by tightening the suture from both ends with fixed weight. The rats subsequently underwent 30 min of ischemia and 90 min of reperfusion through the gentle release of the snare. The sham operation was conducted using the entire surgical protocol described above, without the introduction of LAD ligation and release. An outline of the experimental protocol is shown in Fig 1. 
Analysis of myocardial infarction
Myocardial infarction was analyzed according to heart infarct size determination as previously described (Zhou, et al., 2011) . The rat hearts were reperfused for 90 min, the left ventricle was cut perpendicular to the base-apex axis into six 2-3 mm slices, followed by staining with 1% TTC solution. The images of the slice were captured using a LEICA digital camera 480, and the infarct area in each slice was measured using computed planimetry with the image analysis program ImageJ 1.26 (Wayne Rasband, National Institutes of Health, Bethesda, MD, USA). The myocardial infarct size was calculated by dividing the total infarct weight of each left ventricle by the total weight of the ventricle.
Cardiac function assessment
A Millar P-V catheter (SPR-838, Millar Instruments, Inc., Houston, TX, USA) was inserted into the left ventricular cavity via the right carotid artery. The femoral artery was isolated and cannulated using a PE 50 polyethylene tube connected to a physiological pressure transducer (SP 844, MEMSCAP, Crolles Cedex, France). By PowerLab (ADInstruments Pty Ltd., Castle Hill, Australia), the left ventricle pressure and mean aortic pressure (MAP) were recorded using a Millar catheter and physiological pressure transducer, respectively. Electrocardiogram (ECG) in lead II was also recorded through the needle electrodes attached to the limbs. The left ventricular end diastolic pressure (LVEDP), left ventricular systolic pressure (LVSP), maximum values within a beat of the first derivative of left ventricular pressure (+dp/dt), and heart rate (HR) was calculated from a continuously generated pressure signal for 15min stabilization. The LV P-V loop was acquired using a Millar control unit (MPVS-300/400 system, Millar Instruments, Houston, TX, USA) by transiently compressing the inferior vena cava for 3s-period. The volume calibration of the conductance system was performed as previously described [9] . Briefly, the volume calibration of the catheter was performed using small tubes of known diameters (a calibration cuvette supplied by Millar Instruments) filled with fresh, Fig 1. Outline of the experimental protocol. The experimental protocol used to evaluate the anti-aging effects of RSE against myocardial ischemia and reperfusion (I/R) injury. Young and intermediate-aged rats were fed RSE (80 mg/kg) or vehicle once daily for 90 days. After the last administration on the 90th day, the rats were subjected to LAD occlusion for 30 min ischemia, followed by 90 min reperfusion. slightly heparinized blood. In this calibration, the linear volume-conductance regression of the absolute volume in each cylinder versus the raw signal acquired from the conductance catheter was used as the volume calibration formula. All analyses were performed using the Millar analysis software PVAN 3.4 (Millar Instruments, Houston, TX, USA) according to the manufacturer's instructions.
Caspase-3/7 activity measurement
One hundred milligrams of frozen left ventricular tissue was homogenized with cold buffer (0.1% TritonX-100, 2mM DTT, 5mM MgCl 2 , 25mM HEPES, pH7.5) and centrifuged at 12,000 × g for 30min at°C. The supernatants were collected and caspase-3/7 activity was determined using Apo-ONE Homogeneous Caspase-3/7 Assay kit (G7790, Promega) according to the manufacturer's protocol.
mRNA isolation, cDNA synthesis and quantitative real-time PCR Total RNA was extracted from frozen left ventricular sample by Tissue Total RNA Mini kit (Favorprep, Taiwan) according to the manufacturer`s instruction.1μg RNA was reverse transcribed into cDNA by the transcriptor first strand cDNA synthesis kit (Roche, Basel, Switzerland). The amounts of cDNA were quantified using the SYBR Green I reagent (Roche, Basel, Switzerland) and detected by the Applied Biosystems ViiA™ 7 Real-Time PCR System (Applied Biosystems, Life technologies, NY, USA).
RT-PCR primers, Bcl-2: 5-GCGAAGTGCTATTGGTACCTG-3 (foward) and 5-ATATTT GTTTGGGGCAGGTCT-3 (reverse), Bax: 5-AGAGGCAGCGGCAGTGAT-3 (foward) and 5-AGACACAGTCCAAGGCAGCAG-3 (reverse), β-actin: 5-CTCTGTGTGGATTGGTGG CT-3(foward) and 5-GGGTGTAAAACGCAGCTCAG-3 (revers) from (TECH DRAGON LIMITED, Hong Kong, China). 2-ΔΔCT method was used to quantify gene expression levels.
Western blot analysis
After I/R, the left ventricular samples were homogenized in a buffer containing 20 mM Tris/ HCl, pH 6.8, 1 mM EDTA, 1% SDS, 1 mM PMSF, and 1X protease inhibitor cocktail (Roche, Germany). The cell lysates were immediately centrifuged at 12,000g for 10 minutes at 4°C and the supernatant was the cytosolic fraction. The mitochondrial and nuclear fractions were isolated according to the kit protocol of Qproteome 1 Mitochondria Isolation kit (Qiagen, Hilden, Germany). The protein concentration of cytosolic fraction was quantified by Bio-Rad protein assay kit (Bradford method) (Bio-Rad, CA, USA). The protein concentration mitochondrial and nuclear fractions were determined by BCA protein assay kit (Thermo, Rockford, IL, USA). Equal amounts of proteins (40 μg/cytosolic fraction and 10 μg/ mitochondrial and nuclear fractions) were separated on a 10% SDS/PAGE and transferred onto nitrocellulose membranes (PALL BioTrace, New York, USA). The following antibodies were used to analyze the expression levels: Akt, phospho-Akt (Ser473), eNOS, Erk1/2 and phosphor-Erk1/2 (Thr202/Tyr204), Caspase 7 p20, Sirt1, Sirt3, Caspase 3, Bax, Bcl-2, β-actin, GAPDH, Histone and Cox 4 (Cell Signaling Technology, Danvers, MA, USA or Santa Cruz Biotechnology, Santa Cruz, CA, USA). The protein bands were detected using horseradish peroxidase conjugated secondary antibody (anti-mouse or anti-rabbit, Santa Cruz Biotechnology) and ECL reagent (Amersham Biosciences, Piscataway, NJ, USA) according to the manufacturer's instructions. The densities of immunoreactive bands were quantified using image J software and normalized to loading control, respectively.
Heart histological examination
The heart tissue was fixed in 10% formaldehyde at 4°C for at least 3 h and dissected into 5-μm-thick paraffin sections. The middle ventricular paraffin sections were stained with hematoxylin and eosin and Masson's trichrome for collagenous fibrosis. Evidence of myocardial injury was evaluated by an investigator who was blinded to animal grouping according to a scoring system as described previously [10] , i.e.: 0) nil; 1) minimum (focal myocytes damage); 2) mild (small multifocal degeneration with slight degree of inflammatory process); 3) moderate (extensive myofibrillar degeneration and/or diffuse inflammatory process); and 4) severe (necrosis with diffuse inflammatory process). The score from light microscopy observation was taken for statistical analysis with a nonparametric test.
Measurement of Malondialdehyde (MDA) content
Frozen left ventricular tissue was homogenized and content of MDA was measured with a MDA assay kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China) according to the manufacturer's instruction.
Statistical analysis
The data are presented as the means±SD. The sample size of each group was 6 hearts for infarct size and cardiac function evaluation. The sample size of each group was 4 hearts for western blot, RT-PCR, histological score and caspase activity analysis. Differences of quantitative data among the groups were analyzed using one-way ANOVA. When the ANOVA showed an overall difference, post hoc contrasts were performed between groups using the SNK method. Comparisons of histological scores were analyzed by the non parametric Kruskal-Wallis test and pairwise differences by the Mann-Whitney test. The results were considered significant at p<0.05.
Results

Effects of RSE on myocardial infarct size
In the same open chest model as described above, young rats and intermediate-aged rats received 30 min ischemia and 90 min reperfusion (I/R) or sham operation. As shown in Fig 2, the infarct sizes of the hearts in young and intermediate-aged rats treated with vehicle after I/R were 8.05±0.85% and 14.03±3.38%, respectively, suggesting that intermediate-aged rats showed significantly more severe I/R injury than young rats (P<0.01). RSE treatment for 90 days significantly reduced the myocardial infarct size compared with the respective vehicle control (1.85 ±1.39% in young rats and 2.22±1.24% in intermediate-aged rat, respectively). There was no significant difference in the infarct size between hearts treated with RSE in young or intermediate-aged rats.
Effects of RSE on left ventricular function
There were no significant differences at baseline and after reperfusion in HR and MAP between the groups (Fig 3A) . The RSE-treated hearts in both young and intermediate-aged rats did not significantly alter HR and MAP. Left ventricular function parameters LVSP, LVEDP and LV max dp/dt for intermediate-aged hearts were appreciably changed. RSE treatment for 90 days in intermediate-aged hearts significantly reduced LVEDP and increased LV max dp/dt (P<0.05), but didn't change LVSP. In young hearts, there was no significant difference in LVSP, LVEDP and LVmax dp/dt either at baseline or after reperfusion. 
Effects of RSE on p-Akt, Akt and eNOS expression
Akt proteins in the heart were investigated after 30 min ischemia and 90 min reperfusion through LAD occlusion. As shown in Effects of RSE on p-Erk, Erk and caspase 7 p20 expression
Because RSE induces the survival signals through the Akt/eNOS signaling pathway, we also investigated the activation of Erk with or without RSE treatment. Fig 5 shows 
Effects of RSE on longevity proteins
The expression of the longevity proteins Sirt1 (nuclear) and Sirt3 (mitochondrial) was investigated in young and intermediate-aged rats. Effects of RSE on activated Caspase-3/7 and Bax/Bcl-2 ratio
Effects of RSE on cardiac histological changes
Since one possible apoptotic pathway was the trigger of caspase cascade, we evaluated the Caspase-3/7 activity in the myocardial tissue. As shown in Fig 8A, caspase-3/7 activity showed no change in the young groups with or without RSE treatment, suggesting that the cell apoptosis elicited by I/R in young hearts was independent of the caspase cascade. Fig 8A showed 
Effects of RSE on myocardial MDA content
MDA is biomarkers of ischemia stress in cardiomyocyte, so we measured the content of MDA in left ventricular tissue to evaluate changes in I/R injury. Fig 9. showed that I/R significantly increased content of MDA compared with the sham hearts (in young P<0.01, in 
Discussion
Intrinsic cardiac aging is defined as slowly progressive structural changes and functional declines with age in the absence of major cardiovascular risks. Aging makes the heart more susceptible to stress and contributes to increased cardiovascular mortality and morbidity in the elderly. The epidemiological analysis of patient age subsets showed that the in-hospital mortality of patients with acute myocardial infarction was only 2.5% for young patients compared with 9.0% in middle-aged patients and 21.4% in elderly patients [11] . A number of studies have revealed that the acute myocardial infarction in three age subsets was significantly different in risk factors, clinical features, morbidity and mortality [12, 13] . Although several studies have characterized the cardiovascular system in senescent rats (older than 24 months), only a few studies have examined cardiac function and structural alternations after I/R injury in middleaged rats. In the present study, we directly compared the hearts from young and intermediateaged SD rats and observed an aged-related increase in susceptibility to injury induced through ischemic reperfusion in middle-aged individuals. Using a rat model of LAD ligation, we studied the importance of middle age in the risk of myocardial infarction following I/R and explored the potential mechanism. We showed that 1) intermediate-aged rats had significantly higher infarct expansion than young rats after I/R; 2) left ventricular dysfunction were more severe in intermediate-aged rats compared with young rats; 3) a significant decrease in the levels of phosphorylated Akt and eNOS and the increased expression of phosphorylated Erk and caspase 7 were observed in intermediate-aged rats compared with young rats; 4) lower levels of the longevity proteins Sirt1 and Sirt3 were shown in intermediate-aged rats, indicating a stronger aging response; 5) activation of caspase-3/7 and increase of Bax/Bcl-2 ratio were observed in intermediate-aged rats, revealing myocardial cell apoptosis. Ginseng has been used in traditional Chinese medicine as a panacea that provides eternal youth [14] . The traditional beneficial effects of ginseng were replenishment of vital energy, mood elevation and longevity [15] . Modern pharmacological studies have revealed the effects of ginseng against cardiovascular diseases associated with aging. Several ginsenosides and ginseng extracts have demonstrated the effects of delaying brain or vascular aging both in vitro and in vivo. Treatment with fermented Panax ginseng extract improved the antioxidant status during aging, thereby minimizing oxidative stress and the occurrence of age-related disorders associated with free radicals [16] . The long-term supplementation of ginseng partially prevented the age-related increase in oxidant production and oxidative protein damage in rats through elevated antioxidant enzyme activities [17] . Ginsenosides could protect cardiomyocyte exposed to hypoxic/ischemic injury through mitochondrial apoptotic pathway. Although most studies provide evidence supporting the heart health properties of ginseng, many controversies have been generated about the cardioprotection of ginseng in middle-aged patients. Until recently, no studies have examined cardiac functional and structural alterations after the longterm consumption of ginseng in intermediate-aged myocardium.
To examine the effects of ginseng on cardiac aging using an in vivo system, rodents were selected as an ideal model organism characterized by many significant advantages as an in vivo model animal to address the cardiac aging mechanism. Previous studies showed a significant age-dependent decline in left ventricular function and increased prevalence of mitral regurgitation in rat hearts [18, 19] . An increase in apoptosis is involved in the development and progression of cardiac aging. Blocking it by Ginseng can prevent the loss of contractile muscle cells and attenuate cardiac damage [20] . The results of the present study showed that the decrease in infarction size, through RSE treatment in the hearts of both young and intermediate-aged rats, was accompanied by an increase in left ventricular function and a modest reduction in histological changes. RSE gavage for 90 days increased Akt/eNOS activation and Sirt1 and Sirt3 expression but decreased p-Erk expression in intermediate-aged rats. Consistent with this, we found that RSE attenuated age-dependent myocardial apoptosis as displayed by significant reduction of caspase 3/7 activity and Bax/Bcl-2 ratio. Another line of evidence for the protective role of RSE in intermediate-aged heart was demonstrated by inhibition of myocardial MDA production. The accumulation of MDA has been shown to be correlated with increased apoptosis in cardiac aging [21] . Sirt1 was expressed in the nucleus, while Sirt3 was present in mitochondria. The important roles of Sirt1 and Sirt3 in metabolic responses and cardiac aging-related diseases have been extensively studied [22, 23] . While Sirt activators provide benefits as gatekeepers of cellular longevity, the ability of RSE to potentiate these processes remained unknown. The results obtained in the present indicated that cardiac aging paralleled the suppression of Sirt1 and Sirt3, suggesting that RSE protected the intermediate-aged heart through triggering several longevity genes. Activity of Akt has been demonstrated to play a central role in regulating a variety of cardiac cellular processes ranging from survival to aging. Recent studies have shown that sirtuin isoforms Sirt1, Sirt3 and Sirt6 play an essential role in the regulation of Akt activation [24] . Our previous study showed that RSE protected adult heart against I/R via Akt-activated pathway. Therefore, this manuscript elucidated a possible mechanism for the cardioprotective effect of RSE through Sirt 1 and 3/Akt-mediated pathway in cardiac aging. We found for the first time that Sirt1 and Sirt3 were significant down-regulated in intermediate-aged hearts and 90 days RSE treatment mitigated age-dependent decrease. With I/R alone, cardiomyocyte apoptosis plays an imperative role in the development of cardiac aging and Sirt1 and Sirt3 were increased by RSE treatment contributing to hearts tolerance to I/R stress, which suggested that Sirt1 and Sirt3 played an anti-apoptotic role and were involved in the cardioprotection of RSE in intermediate-aged hearts. The analysis of heart fibrosis according to age subsets showed augmentation with aging [25] . In the present study, we showed increased fibrotic infiltration in intermediate-aged rats compared with young rats with the sham operation. The histological observation revealed increased collagen cross-linking in the endocardium but not in the epicardium, indicating an increase in cardiac fibrosis in middle-aged hearts. After RSE treatment for 90 days, there was no comparable fibrosis in noninfarct and infarct regions. We initially expected that the infarcts would be smaller in middle-aged hearts after RSE treatment, consistent with the reduced collagen content. A potential explanation for this result is that the activation of collagen matrix degradation was triggered through the initiation of the inflammatory response in the infarcted tissue. A stepwise increase in MMP activity has been reported after myocardium infarction [26] . We did not obtain measurements of LV remodeling after acute ischemia reperfusion, potentially indicating the effect of RSE on the extent of collation degradation following myocardium infarct.
Cardiac aging involves a complex network of molecular signals, included mitochondrial oxidative stress, insulin/insulin-like growth factor/PI3K, adrenergic and renin angiotensin II signaling and nutrient signaling pathways [27] . In heart aging, many changes, such as increased cardiomyocyte death [28] , extracellular matrix remodeling [29, 30] , hypoxia response, angiogenesis [31] and energetic abnormalities [32] , predispose the aging heart to the development of heart failure. The anti-aging activity of ginseng was initially supported by evidence showing increased antioxidant enzyme activity. While there is little controversy regarding the effects of antioxidant intervention in cardiac aging, there is a considerable debate concerning whether ginseng protects the aged heart [33] .
In conclusion, the results of the present study provided the first demonstration that the long-term consumption of ginseng extract protects intermediate-aged hearts against I/R injury by reducing myocardial infarct size, improving left ventricular function, inhibiting caspase-3/7 activation, decreasing Bax/Bcl-2 ratio and MDA. Ginseng extract potentiated cardioprotective effects through the activation of Akt/eNOS survival signals and the suppression of apoptotic Erk/caspase 7 signaling. In addition, ginseng extract triggered the activation of Sirt1 and Sirt3, suggesting an anti-aging effect. Therefore, we propose that ginseng extract RSE might be used an effective drug for the prevention of aged-related cardiac function deficits and other ventricular changes induced after acute ischemic reperfusion.
